Cytokine signaling in macrophages: beyond JAK-STAT

CYTOMAC aims to identify cytokine-specific transcription factors in macrophages to improve targeted therapies for inflammatory diseases by leveraging genetic diversity in mouse models.

Subsidie
€ 1.500.000
2023

Projectdetails

Introduction

Dysregulated macrophage function underlies many inflammatory diseases. Cytokines, small secreted signaling molecules with immune-modulatory functions, shape the macrophage’s phenotype, thereby affecting disease states. Puzzlingly, many cytokines with opposing functions utilize highly similar JAK-STAT signaling cascades, leaving it unclear how cytokine-specific responses can occur.

Previous Work

In my previous work, I studied enhancer activation in mouse macrophages from genetically different strains. By studying genetic variation, I found that transcription factor (TF) motifs crucial for enhancer activation can be identified. I further developed the bio-informatic tool MAGGIE to study TF motif mutations in different strains of mice, which subsequently enabled me to discover a novel TF important for enhancer activation by the cytokine interleukin-4.

Hypothesis

Based on my findings, I hypothesize that cytokines require specific, yet unidentified TFs that cooperate with JAK-STAT signaling to mount cytokine-specific effects.

Project Goals

CYTOMAC aims to identify these cytokine-specific TFs downstream of JAK-STAT that direct appropriate cell responses. I will exploit the genetic variation across mouse strains and study enhancer activation in macrophages from these strains in response to different disease-related cytokines. Specifically, I will:

  1. Use genetic diversity between mouse strains to identify specific TFs regulating cytokine-specific responses.
  2. Target these novel TFs in mouse macrophages.
  3. Target these novel TFs in human macrophages.
  4. Translate my findings to human disease and inflammatory disease models.

Clinical Relevance

Inhibitors targeting JAK-STAT show high potential in clinically treating inflammatory diseases, including rheumatoid arthritis. However, as they affect generic pathways of many cytokines, they come with considerable side effects, limiting applicability. CYTOMAC will reveal novel, cytokine-specific TFs, which will aid in developing better tailored intervention strategies.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.500.000
Totale projectbegroting€ 1.500.000

Tijdlijn

Startdatum1-9-2023
Einddatum31-8-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • STICHTING AMSTERDAM UMCpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC COG

Decoding and targeting the PGE2-MEF2A axis in tumor-associated macrophages

The MEFHISTO project aims to explore the PGE2-MEF2A pathway in tumor-associated macrophages to develop novel immunotherapy strategies for pancreatic cancer.

€ 2.000.000
ERC COG

Negative Regulation of Inflammatory Responses Revealed with Camelid Nanobodies

The project aims to develop new cell biology tools to uncover intricate signaling networks that downregulate inflammation, focusing on the roles of NLRC3 and NLRX1 in controlling pro-inflammatory responses.

€ 1.997.828
ERC ADG

Targeting mechanisms of Thrombo-inflammation

This project aims to elucidate the molecular mechanisms of thrombo-inflammation through the novel TF-IFNAR1 heterodimer, potentially leading to innovative diagnostics and therapies for related diseases.

€ 2.499.000
ERC POC

Targeted Immunocytokines by CaGing and local Release

This project aims to develop and evaluate a novel, locally activated innate immune therapy for cancer that minimizes systemic toxicity while enhancing treatment efficacy.

€ 150.000